Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Pancreatic Neoplasms 1Muscle Invasive Bladder Carcinoma 1Muscle Invasive Bladder Cancer 1HER2 1Carcinoma, Transitional Cell 1Breast Neoplasms 1

Interventions

disitamab vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Muscle Invasive Bladder Carcinoma × disitamab vedotin × Clear all
NCT06074484 2023-10-10

A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Unknown
36 enrolled

Muscle Invasive Bladder Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡